Dr. Reddy’s (NYSE: RDY) sets Feb 23 Mumbai investor meetings

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited has notified exchanges that its management will participate in an investor conference organized by Kotak Institutional Equities. The meetings are scheduled in Mumbai on 23 February 2026, will be held in person, and structured as group meets from 09:00 to 17:00 IST. The company notes the schedule may change if required by either the investors or the company.

Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

February, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                               Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                               No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated February 12, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED  (Registrant)
Date: February 12, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

	Dr. Reddy's Laboratories Ltd.
	8-2-337, Road No. 3, Banjara Hills
	Hyderabad – 500 034, Telangana, India
	CIN: L85195TG1984PLC004507
	Tel:       + 91 40 4900 2900
	Fax:     + 91 40 4900 2999
	Email: mail@drreddys.com
	Web:   www.drreddys.com

February 12, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform that the Company’s management will be participating in the following investor conference with single institution(s)/ investor groups:

Date	Organized by	Location	Meeting mode	Nature of meet	Timing
23.02.2026	Kotak Institutional Equities	Mumbai	In – Person	Group Meet	09:00 - 17:00 IST

Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors / Company.

This is for your information. 

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

FAQ

What does Dr. Reddy’s Laboratories (RDY) announce in this Form 6-K?

Dr. Reddy’s announces its management will attend an investor conference organized by Kotak Institutional Equities in Mumbai on 23 February 2026. The filing shares the schedule details for analyst and institutional investor meetings under Regulation 30 disclosure requirements.

When are Dr. Reddy’s (RDY) analyst and institutional investor meetings scheduled?

The analyst and institutional investor meetings are scheduled for 23 February 2026, between 09:00 and 17:00 IST. These meetings will occur during a Kotak Institutional Equities conference in Mumbai and are structured as group meetings with single institutions or investor groups.

Where will Dr. Reddy’s (RDY) investor conference meetings take place?

The meetings will take place in Mumbai at an investor conference organized by Kotak Institutional Equities. Management will attend in person, engaging in group meetings with institutional investors and analysts during a full-day schedule from 09:00 to 17:00 IST on 23 February 2026.

What is the nature and mode of Dr. Reddy’s (RDY) investor meetings?

The meetings are described as in-person, group meetings with institutional investors and analysts. Company management will participate physically in Mumbai, meeting single institutional investors or investor groups throughout the day as part of the Kotak Institutional Equities investor conference schedule.

Can the schedule of Dr. Reddy’s (RDY) investor meetings change?

Yes, the company states that the schedule of the planned investor meetings may change due to exigencies affecting either the investors or Dr. Reddy’s. This caveat signals that timing or participation could be adjusted if unforeseen circumstances arise for the parties involved.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 39.4 KB